Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | insulin receptor | 0.0049 | 0.0587 | 0.0545 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0311 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.1585 | 0.1547 |
Schistosoma mansoni | tyrosine kinase | 0.0049 | 0.0587 | 0.0545 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Schistosoma mansoni | tyrosine kinase | 0.0049 | 0.0587 | 0.0545 |
Echinococcus multilocularis | ephrin type A receptor 4 A | 0.0133 | 0.3609 | 0.3581 |
Brugia malayi | Pre-SET motif family protein | 0.0235 | 0.7271 | 0.7259 |
Plasmodium vivax | SET domain protein, putative | 0.0034 | 0.0045 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Loa Loa (eye worm) | glutaminase 2 | 0.0308 | 0.9916 | 0.9915 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0034 | 0.0045 | 0.0045 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0311 | 1 | 1 |
Leishmania major | 0.0311 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0988 | 0.0948 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0311 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.015 | 0.422 | 0.4194 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.015 | 0.422 | 0.4194 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.1585 | 0.1585 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0081 | 0.175 | 0.175 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0311 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.175 | 0.1713 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0311 | 1 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0308 | 0.9916 | 1 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0053 | 0.0746 | 0.0746 |
Mycobacterium ulcerans | glutaminase | 0.0308 | 0.9916 | 0.5 |
Toxoplasma gondii | sedoheptulose-1,7-bisphosphatase | 0.0115 | 0.2987 | 0.2955 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0053 | 0.0746 | 0.0705 |
Loa Loa (eye worm) | glutaminase | 0.0308 | 0.9916 | 0.9915 |
Echinococcus granulosus | epidermal growth factor receptor | 0.015 | 0.422 | 0.422 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Brugia malayi | glutaminase DH11.1 | 0.0308 | 0.9916 | 0.9915 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0049 | 0.0587 | 0.0545 |
Schistosoma mansoni | glutaminase | 0.0308 | 0.9916 | 0.9915 |
Echinococcus granulosus | ephrin type A receptor 4 A | 0.0133 | 0.3609 | 0.3609 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0311 | 1 | 1 |
Onchocerca volvulus | 0.0118 | 0.3067 | 0.3601 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0081 | 0.175 | 0.1713 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.015 | 0.422 | 0.4194 |
Brugia malayi | Protein kinase domain containing protein | 0.0049 | 0.0587 | 0.0545 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0311 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Brugia malayi | ephrin receptor 1 precursor | 0.0058 | 0.0906 | 0.0865 |
Echinococcus granulosus | insulin receptor | 0.0049 | 0.0587 | 0.0587 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | TK/EPH protein kinase | 0.0152 | 0.4304 | 0.4279 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0081 | 0.175 | 0.175 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.1585 | 0.1547 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0311 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus multilocularis | 0.0046 | 0.0487 | 0.0444 | |
Onchocerca volvulus | 0.0267 | 0.8437 | 1 | |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.175 | 0.1713 |
Toxoplasma gondii | fructose-bisphospatase I | 0.0115 | 0.2987 | 0.2955 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0235 | 0.7271 | 0.7259 |
Schistosoma mansoni | ephrin receptor | 0.012 | 0.3144 | 0.3113 |
Loa Loa (eye worm) | hypothetical protein | 0.0118 | 0.3067 | 0.3036 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.015 | 0.422 | 0.4194 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.